MODERN DIAGNOSTICS AND TREATMENT OF PATIENTS WITH SAUSAGE-POISONING (GUIDELINES)
DOI:
https://doi.org/10.11603/1681-2727.2019.4.10958Keywords:
sausage-poisoning, clinical presentation, diagnostics, treatment, antitoxic serum, biological weaponAbstract
Methodical recommendations are made taking into account modern information about clinical displays of food, wound, paratherapeutic, inhalation sausage-poisoning and illness for babies. Clinical presentation of food, wound, paratherapeutic, inhalation and “child’s” sausage-poisoning is similar and presents in the bilateral paralysis of cranial nerves; dyspepsia manifestations; respiratory disfunction; absence of fever, confusing of consciousness, dormancy, violation of sensitiveness.
Objective displays over are brought at a physical inspection, methods of laboratory diagnostics. Risk of disease factors are distinguished. Standard laboratory diagnostics of sausage-poisoning is based on the exposure of toxin in a serum, gastric secret, fecal masses and standards of foods of feed by raising of bioassey on mice, now and then – bacteriological and electro-physiology research, immune enzymic analysis, PCR.
Treatment of patients with different clinical forms of sausage-poisoning were analyzed in detail. Taking into account absence of domestic immunobiological drugs, collected information about anti-sausage-poisoning medicines by different producers, that allows to use accessible in concrete terms foreign drugs. The different methods of avoidance of heavy complications are considered after antitoxic therapy.
The prospect of the use of effective and safe vaccines from sausage-poisoning was discussed.
References
Hatheway, C. L., & Johnson, E. A. (1998). Clostridium: the spore-bearing anaerobes.
Fu, F. N., Lomneth, R. B., Cai, S., & Singh, B. R. (1998). Role of zinc in the structure and toxic activity of botulinum neurotoxin. Biochemistry, 37 (15), 5267-5278. DOI: https://doi.org/10.1021/bi9723966
Lacy, D. B., Tepp, W., Cohen, A. C., DasGupta, B. R., & Stevens, R. C. (1998). Crystal structure of botulinum neurotoxin type A and implications for toxicity. Nature Structural Biology, 5 (10), 898-902. DOI: https://doi.org/10.1038/2338
Doyle, M. (Ed.). (1989). Foodborne bacterial pathogens. CRC Press.
BMJ Best Practice. Botulism. (2018). [Electronic resource]. Retrieved from: bestpractice.bmj.com [in Ukrainian].
Feigin, R. D., & Cherry, J. D. (1998). Textbook of pediatric infectious diseases (No. 616.9-053.2). WB Saunders.
Black, J. D., & Dolly, J. O. (1986). Interaction of 125I-labeled botulinum neurotoxins with nerve terminals. II. Autoradiographic evidence for its uptake into motor nerves by acceptor-mediated endocytosis. The Journal of Cell Biology, 103 (2), 535-544.
Blasi, J., Binz, T., Yamasaki, S., Link, E., Niemann, H., & Jahn, R. (1994). Inhibition of neurotransmitter release by clostridial neurotoxins correlates with specific proteolysis of synaptosomal proteins. Journal of Physiology-Paris, 88 (4), 235-241. DOI: https://doi.org/10.1016/0928-4257(94)90086-8
Nowakowski, J. L., Courtney, B. C., Bing, Q. A., & Adler, M. (1998). Production of an expression system for a synaptobrevin fragment to monitor cleavage by botulinum neurotoxin B. Journal of Protein Chemistry, 17 (5), 453-462. DOI: https://doi.org/10.1023/A:1022570518330
Shapiro, R. L., Hatheway, C., & Swerdlow, D. L. (1998). Botulism in the United States: a clinical and epidemiologic review. Annals of Internal Medicine, 129 (3), 221-228. DOI: https://doi.org/10.7326/0003-4819-129-3-199808010-00011
Cherington, M. (2004). Botulism: update and review. In Seminars in neurology (Vol. 24, No. 02, pp. 155-163). Copyright© 2004 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. DOI: https://doi.org/10.1055/s-2004-830901
Istre, G. R., Compton, R., Novotny, T., Young, J. E., Hatheway, C. L., & Hopkins, R. S. (1986). Infant botulism: three cases in a small town. American Journal of Diseases of Children, 140 (10), 1013-1014. DOI: https://doi.org/10.1001/archpedi.1986.02140240059027
Andreychyn, M., & Kopcha, V. (2005). Bioterrorism: a medical counter. Ternopil: Ukrmedknyha [in Ukrainian].
Dowell, V. R., McCroskey, L. M., Hatheway, C. L., Lombard, G. L., Hughes, J. M., & Merson, M. H. (1977). Coproexamination for botulinal toxin and Clostridium botulinum: a new procedure for laboratory diagnosis of botulism. Jama, 238 (17), 1829-1832. DOI: https://doi.org/10.1001/jama.1977.03280180033021
Sobel, J., Dill, T., Kirkpatrick, C. L., Riek, L., Luedtke, P., & Damrow, T. A. (2009). Clinical recovery and circulating botulinum toxin type F in adult patient. Emerging Infectious Diseases, 15 (6), 969. DOI: https://doi.org/10.3201/eid1506.070571
Brook, I. (2007). Infant botulism. Journal of Perinatology, 27 (3), 175-180. DOI: https://doi.org/10.1038/sj.jp.7211651
Torre, M. D., Stecchini, M. L., & Peck, M. W. (1998). Investigation of the ability of proteolytic Clostridium botulinum to multiply and produce toxin in fresh Italian pasta. Journal of Food Protection, 61 (8), 988-993. DOI: https://doi.org/10.4315/0362-028X-61.8.988
Rodriguez, A., & Dezfulian, M. (1997). Rapid identification ofClostridium botulinum and botulinal toxin in food. Folia Microbiologica, 42 (2), 149-151. DOI: https://doi.org/10.1007/BF02898726
Lindström, M., & Korkeala, H. (2006). Laboratory diagnostics of botulism. Clin. Microbiol. Rev., 19, 298-314. DOI: https://doi.org/10.1128/CMR.19.2.298-314.2006
Gottlieb, S. L., Kretsinger, K., Tarkhashvili, N., Chakvetadze, N., Chokheli, M., Chubinidze, M., ... & Sikharulidze, M. (2007). Long-term outcomes of 217 botulism cases in the Republic of Georgia. Clinical Infectious Diseases, 45 (2), 174-180. DOI: https://doi.org/10.1086/518890
July, T. O. (2007). Botulism associated with commercially canned chili sauce – Texas and Indiana, July 2007. Morbidity and Mortality Weekly Report, 56.
Sheth, A. N., Wiersma, P., Atrubin, D., Dubey, V., Zink, D., Skinner, G., ... & Drenzek, C. (2008). International outbreak of severe botulism with prolonged toxemia caused by commercial carrot juice. Clinical Infectious Diseases, 47 (10), 1245-1251. DOI: https://doi.org/10.1086/592574
Werner, S. B., Passaro, D., McGee, J., Schechter, R., & Vugia, D. J. (2000). Wound botulism in California, 1951–1998: recent epidemic in heroin injectors. Clinical Infectious Diseases, 31 (4), 1018-1024. DOI: https://doi.org/10.1086/318134
Partikian, A., & Mitchell, W. G. (2007). Iatrogenic botulism in a child with spastic quadriparesis. Journal of Child Neurology, 22 (10), 1235-1237. DOI: https://doi.org/10.1177/0883073807306269
Crowner, B. E., Brunstrom, J. E., & Racette, B. A. (2007). Iatrogenic botulism due to therapeutic botulinum toxin a injection in a pediatric patient. Clinical Neuropharmacology, 30 (5), 310-313. DOI: https://doi.org/10.1097/WNF.0b013e31804b1a0d
Kopcha, V. S., & Borak, V. T. (2014). The case of “injection botulism”. Infectious Diseases, (4) [in Ukrainian].
Shelley, E. B., O’rourke, D., Grant, K., McArdle, E., Capra, L., Clarke, A., ... & Cosgrove, C. (2015). Infant botulism due to C. butyricum type E toxin: a novel environmental association with pet terrapins. Epidemiology & Infection, 143 (3), 461-469.
Iida, H., Ono, T., & Karashimada, T. (1966). Studies on the serum therapy of type E botulism. Botulism, 346-362.
Proceedings of the Fifth International Symposium on Food Microbiology. Moscow, July 1966. (1967). London, Chapman & Hall.
American Academy of Pediatrics: Report of the Committee on Infectious Diseases, 23rd ed. (1994). Elk Grove Village, IL., The Academy.
Nemekin, V. N., & Ryabinin, O. N. (2015). Toxins and assessment of their damaging effect. Modern Technologies for Civil Defense and Emergency Response, 2 (1 (6)).
Centers for Disease Control and Prevention (CDC). (2011). Notice of CDC’s discontinuation of investigational pentavalent (ABCDE) botulinum toxoid vaccine for workers at risk for occupational exposure to botulinum toxins. MMWR. Morbidity and Mortality Weekly Report, 60 (42), 1454.
Przedpelski, A., Tepp, W. H., Zuverink, M., Johnson, E. A., Pellet, S., & Barbieri, J. T. (2018). Enhancing toxin-based vaccines against botulism. Vaccine, 36 (6), 827-832. DOI: https://doi.org/10.1016/j.vaccine.2017.12.064
Downloads
Published
How to Cite
Issue
Section
License
Journal Infectious Disease (Infektsiini Khvoroby) allows the author(s) to hold the copyright without registration
Users can use, reuse and build upon the material published in the journal but only for non-commercial purposes
This journal is available through Creative Commons (CC) License BY-NC "Attribution-NonCommercial" 4.0
